Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -10.54 | 22.44 |
| PEG Ratio (TTM) | -0.47 | 2.86 |
| P/S Ratio (TTM) | 0.04 | 0.35 |
| P/B Ratio (TTM) | 0.72 | 9.65 |
| P/FCF Ratio (TTM) | -12.84 | 14.67 |
| Price to 5YR AVG Earnings Ratio | 179.42 | 50.41 |
| Price to 5YR AVG FCF Ratio | 17.84 | 10.17 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.49% | 5.32% |
| ROE (TTM) | -6.67% | 50.07% |
| Net Profit Margin (TTM) | -0.36% | 1.54% |
| ROIC 5YR AVG | 4.40% | 13.71% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2.98% | 40.15% | -39.77% |
| Revenue | 2.49% | -21.69% | 48.11% |
| Net Income | -3.00% | 42.64% | -39.18% |
| Cash Flow | -3.72% | -63.59% | 17.59% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.44 | 1.41 |
| Quick Ratio (TTM) | 0.52 | 0.80 |
| D/E Ratio (TTM) | 2.16 | 3.51 |
| Interest Coverage (TTM) | 0.41 | 4.41 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 4.62 | 5.30 |
| LTL to 5YR AVG FCF | 50.69 | 11.74 |
| Shares Outstanding Growth 5YR AVG | 2.10% | 2.15% |